Oku H, Shimizu T, Kawabata T, et al: Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. Eur J Pharmacol 590: 400-408, 2008
Oku H, Nakazato H, Horikawa T, et al: Pirfenidone suppresses tumor necrosis factor-alpha, enhances interleukin-10 and protects mice from endotoxic shock. Eur J Pharmacol 446: 167-176, 2002
Garcia L, Hernandez I, Sandoval A, et al: Pirfenidone effectively reverses experimental liver fibrosis. J Hepatol 37: 797-805, 2002
Shimizu T, Kuroda T, Hata S, et al: Pirfenidone improves renal function and fibrosis in the postobstructed kidney. Kidney Int 54: 99-109, 1998
Raghu G, Johnson WC, Lockhart D, et al: Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study. Am J Respir Crit Care Med 159: 1061-1069, 1999